Arkolith/Insider Trading/TEVA/Form 4

Savage Brian

Interim Chief Legal OfficerTEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) · full profile →Form 4 · filed Mar 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$36K
Net Open-Market Flow
-$36K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 5, 2026Option exercise(M)4K——12K
Mar 5, 2026Sell(S)1K$31.67$36K11K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 5, 2026Option exercise(M)4K—$011K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-098501) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML